| 名稱 | B2M-associated HLA-G/aAPC Cell |
| 型號(hào) | CBP74189 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | B2M-associated HLA-G/aAPC Cell |
產(chǎn)品搜索
相關(guān)文章
- 建立ATCC細(xì)胞系的要求
- 腫瘤細(xì)胞的凋亡與壞死有何區(qū)別？
- STING激動(dòng)劑和拮抗劑的篩選
- IHC第三方質(zhì)控品——病理質(zhì)控基石，精準(zhǔn)診斷起點(diǎn)
- 【新品發(fā)布】DdPCR試劑盒開發(fā)與驗(yàn)證
- 【連載-Toll樣受體系列2】TLR7激動(dòng)劑藥物細(xì)胞篩選模型
- JCI:華人科學(xué)家發(fā)現(xiàn)促進(jìn)乳腺癌進(jìn)展轉(zhuǎn)移的表觀修飾閱讀者
- IL10及其受體細(xì)胞篩選模型
- 腫瘤細(xì)胞分裂“制動(dòng)系統(tǒng)”相關(guān)基因分析
- eLife：為何肺癌靶向治療會(huì)失??？看看科學(xué)家們?cè)趺凑f
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74189B2M-associated HLA-G/aAPC Cell
- 詳細(xì)內(nèi)容
| CBP74189 | |
| I. Background | |
| N/A | |
| II. Introduction | |
| Host Cell: | N/A |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS+600ug/ml Hygromycin B+3ug/ml puromycin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
Figure 1. Recombinant B2M-associated HLA-G/aAPC Cell stably expressing B2M.
Figure 2. Recombinant B2M-associated HLA-G/aAPC Cell stably expressing HLA-G.
Figure 3. Dose Response of LILRB1 Blocking Antibody in LILRB1 Effector Reporter Cells (C13) With B2M-associated HLA-G/aAPC Cells (C15).
Figure 4.Dose Response of LILRB2 Blocking Antibody in LILRB2 Effector Reporter Cells (C24) With B2M-associated HLA-G/aAPC Cells(C15). | |
會(huì)員_a.png)